This has occurred partly due to the very success of these drugs, and the lack of availability may result in patients being unable to persist with the drug
Benefits include: Average weight loss of up to 15 to 25% in clinical studies Improved portion control and satiety Support for balancing blood sugar and metabolic health GLP-1/GIP Dual Agonists These advanced options activate both GLP-1 and GIP (gastric inhibitory polypeptide) receptors for enhanced appetite control, glucose balance, and fat metabolism
Follow the frequency (once-weekly) and recommended dose escalation schedule carefully to reduce stomach-related side effects
[DOI] [PubMed] [Google Scholar] 41.Sanyal Arun J, Pierre B, Mandy F, Neff Guy W, Eric L, Elisabetta B et al
10.1111/anu.12428 54 SaitoY
A., Borum, P., Stall, C., Millspaugh, J., Taggart, E., and Lum, G